Adenomyosis happens when endometrial-type tissue grows into the uterine muscle wall instead of staying only on the lining. The uterus often becomes bulky, tender, and more inflamed during periods. Many women describe progressively heavier bleeding and deeper cramping than ordinary Painful Periods (Dysmenorrhea) in India: Why It Hurts and What Actually Brings Relief.

In India, adenomyosis is likely underdiagnosed because symptoms are often normalized or confused with fibroids, endometriosis, or routine heavy periods. Current estimates suggest it may affect around one in five reproductive-age women, though exact prevalence varies by ultrasound and MRI criteria. A careful pelvic exam plus imaging usually clarifies the picture.

Treatment is usually needed when symptoms are affecting daily life. Common triggers are heavy bleeding, anemia, severe cramps, pelvic pressure, pain with intercourse, missed work, fatigue, or repeated emergency visits for bleeding and pain.

If adenomyosis is found on scan but the woman has no meaningful symptoms, active treatment is usually not necessary. Monitoring, iron status checks, and review if symptoms change are often enough. The goal is symptom control, not treating a scan report in isolation.

The first step is often symptom control with NSAIDs during periods. Indian prescriptions commonly use mefenamic acid combinations such as Mefkind-MF or ibuprofen brands such as Brufen 400. These reduce prostaglandin-driven pain and can modestly reduce menstrual blood loss when started early in the bleed.

Hormonal tablets are the next rung. Combined pills such as Yasmin, Yamini-Plus, or Diane-35 can reduce bleeding by roughly 30 to 50 percent in some women and make cycles more predictable. Oral progestins such as norethisterone are useful when estrogen is unsuitable or short-term cycle control is needed, especially in women with Heavy Menstrual Bleeding (Menorrhagia) in India: Causes, Diagnosis, and the Full Treatment Ladder.

For many Indian women with symptomatic adenomyosis, the levonorgestrel-releasing IUD is the most practical long-term option. Mirena is inserted in clinic, usually costs about Rs. 14,000 to Rs. 22,000, and releases hormone directly inside the uterus with much lower whole-body exposure than daily tablets. For method comparison, see Copper IUD vs Mirena in India: A Plain-Language Comparison.

Bleeding often falls by about 70 to 95 percent over six months, and period pain usually improves as well. It lasts up to five years, helps preserve the uterus, and is especially useful for women who want fertility-sparing symptom control. The tradeoff is irregular spotting in the first months, and expulsion can be slightly more common in a bulky adenomyotic uterus.

GnRH agonists such as leuprolide, sold in India as Lupride, temporarily switch off ovarian hormone production and induce a reversible menopause-like state. This can shrink adenomyosis activity, reduce bleeding, and give short-term pain relief when symptoms are severe or surgery is being planned. Monthly injections often cost around Rs. 3,500 to Rs. 8,000.

These drugs are usually limited to about six months because low estrogen causes hot flushes, mood change, and bone loss. In practice they are most useful as a bridge before surgery, before fertility treatment, or to improve anemia and pelvic pain for a limited period rather than as a permanent solution.

Uterine artery embolization is an interventional radiology procedure that blocks part of the blood supply feeding adenomyotic tissue. It preserves the uterus and can reduce bleeding, pressure, and pain without major abdominal surgery. In Indian private hospitals such as Apollo or Manipal, costs are commonly around Rs. 1 lakh to Rs. 2 lakh.

UAE is generally considered more suitable for women who want to avoid hysterectomy but have completed childbearing. Recovery is usually two to four weeks. Fertility after UAE is less predictable than after medical treatment, so it is not the first choice for women actively trying to conceive soon.

Endometrial ablation destroys the uterine lining to reduce menstrual bleeding. In India, techniques such as NovaSure or Thermachoice may cost about Rs. 40,000 to Rs. 80,000 in private care. It can help women whose main complaint is heavy bleeding and who have completed their family.

The limitation is that adenomyosis often extends deep into the uterine muscle, beyond the lining itself. That means ablation is not a true cure and may not control pain or bulk symptoms well in deeper disease. Pregnancy is unsafe after ablation, so it is only for women who do not want future fertility.

Hysterectomy is the only true cure for adenomyosis because it removes the diseased uterus. It is considered when symptoms remain severe despite medicines or procedures, when anemia is persistent, or when a woman has completed childbearing and wants definitive relief. Laparoscopic hysterectomy is usually preferred when surgical expertise is available.

Private costs are often about Rs. 1 lakh to Rs. 3 lakh, while major government centers such as AIIMS may offer care at low cost or free depending on eligibility. The ovaries are usually preserved if they are healthy, so hysterectomy for adenomyosis does not automatically mean surgical menopause.

Adenomyosis is associated with subfertility, implantation problems, and a higher miscarriage risk in some women. That makes treatment timing important. The plan for a 29-year-old trying to conceive is very different from the plan for a 42-year-old with severe bleeding and completed family.

Short courses of GnRH analogs before IVF may improve outcomes in selected patients, and fertility-preserving choices such as Mirena removal followed by planned conception can be discussed case by case. Women trying naturally or through IVF should work with an ISAR-linked fertility specialist and gynecologist together rather than choosing treatment in isolation.

The practical Indian ladder is shaped by cost and access. Mirena is usually Rs. 14,000 to Rs. 22,000, Lupride roughly Rs. 3,500 to Rs. 8,000 per month, UAE around Rs. 1 lakh to Rs. 2 lakh, and hysterectomy commonly Rs. 1 lakh to Rs. 3 lakh in private hospitals. Consultation with a gynecologist, laparoscopic surgeon, or gynecologic surgeon in large private chains often costs Rs. 800 to Rs. 3,000.

Government hospitals can make definitive care far more affordable, especially for surgery. AIIMS and other public teaching hospitals may offer hysterectomy workup and surgery at low cost or free. Coverage pathways are inconsistent, but expensive imaging and surgical evaluation are often easier to access in tertiary centers than long-term branded medicines.